12 new medicines recommended for approval; another six medicines recommended for extension of their therapeutic indications 12 new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended 12 medicines for approval at its February 2026 meeting. The committee recommended granting a marketing authorisation for mCombriax (influenza and COVID-19 mR... [6115 chars]